BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 21052043)

  • 1. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
    Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H
    Lancet Psychiatry; 2024 Jun; 11(6):443-450. PubMed ID: 38697177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional mental capacity, treatment as usual and time: magnitude of change in secure hospital patients with major mental illness.
    Dornan J; Kennedy M; Garland J; Rutledge E; Kennedy HG
    BMC Res Notes; 2015 Oct; 8():566. PubMed ID: 26467781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.
    McCutcheon R; Beck K; D'Ambrosio E; Donocik J; Gobjila C; Jauhar S; Kaar S; Pillinger T; Reis Marques T; Rogdaki M; Howes OD
    Acta Psychiatr Scand; 2018 Jan; 137(1):39-46. PubMed ID: 29072776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of suicidal behavior and clozapine prescribing among people with schizophrenia in China: a cohort study.
    Yin Y; Lin C; Wei L; Tong J; Huang J; Tian B; Tan S; Wang Z; Yang F; Tong Y; Chen S; Hong LE; Tan Y
    BMC Psychiatry; 2024 Jun; 24(1):440. PubMed ID: 38867174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review.
    Skoretz P; Tang C
    CNS Spectr; 2016 Dec; 21(6):445-449. PubMed ID: 27181114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine.
    Simon GE; Rossom RC; Iturralde E; Ahmedani BK; Waring SC; Owen-Smith AA; Sterling SA; Miley K; Stults CD; Daida YG; Lynch FL; Beck A; Sanchez K; Coleman KJ; Shortreed SM
    J Clin Psychiatry; 2024 Apr; 85(2):. PubMed ID: 38696137
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of time to clozapine prescription on the clinical outcome.
    Muñoz-Manchado LI; Perez-Revuelta JI; Banerjee A; Galindo-Guarin L; Bernardo M; González-Saiz F; Villagrán-Moreno JM; Fernández-Egea E
    Schizophr Res; 2024 Jun; 268():189-192. PubMed ID: 37805277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Tsukahara M; So R; Yoshimura Y; Yamashita R; Yada Y; Kodama M; Nakajima S; Kishi Y; Takeda T; Yamada N; Takeuchi H
    Acta Psychiatr Scand; 2023 Nov; 148(5):437-446. PubMed ID: 37681448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.
    Fonseca de Freitas D; Kadra-Scalzo G; Agbedjro D; Francis E; Ridler I; Pritchard M; Shetty H; Segev A; Casetta C; Smart SE; Downs J; Christensen SR; Bak N; Kinon BJ; Stahl D; MacCabe JH; Hayes RD
    J Psychopharmacol; 2022 Apr; 36(4):498-506. PubMed ID: 35212240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID).
    Ponsford MJ; Steven R; Bramhall K; Burgess M; Wijetilleka S; Carne E; McGuire F; Price CR; Moody M; Zouwail S; Tahir T; Farewell D; El-Shanawany T; Jolles SRA
    J Clin Pathol; 2020 Sep; 73(9):587-592. PubMed ID: 32094276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neutrophil trajectory following clozapine may predict clozapine response - Results from an observational study using electronic health records.
    Jones R; Morales-Munoz I; Shields A; Blackman G; Legge SE; Pritchard M; Kornblum D; MacCabe JH; Upthegrove R
    Brain Behav Immun; 2023 Oct; 113():267-274. PubMed ID: 37494985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in schizophrenia-spectrum diagnoses: results from a 30-year health record registry.
    Ferrara M; Curtarello EMA; Gentili E; Domenicano I; Vecchioni L; Zese R; Alberti M; Franchini G; Sorio C; Benini L; Little J; Carozza P; Dazzan P; Grassi L
    Arch Womens Ment Health; 2024 Feb; 27(1):11-20. PubMed ID: 37730924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia.
    Dong S; Schneider-Thoma J; Bighelli I; Siafis S; Wang D; Burschinski A; Schestag K; Samara M; Leucht S
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):917-928. PubMed ID: 37526675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
    Masuda T; Misawa F; Takase M; Kane JM; Correll CU
    JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K; Morriss R
    Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R; Dernovsek MZ; Zvan V
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine as treatment of first choice in first psychotic episodes. What do we know?
    Vera I; Rezende L; Molina V; Sanz-Fuentenebro J
    Actas Esp Psiquiatr; 2012; 40(5):281-9. PubMed ID: 23076611
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.